OVERSEA CHINESE BANKING Corp Ltd purchased a new stake in Ventas, Inc. (NYSE:VTR – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 26,540 shares of the real estate investment trust’s stock, valued at approximately $2,357,000.
Several other hedge funds have also recently modified their holdings of VTR. Angeles Wealth Management LLC boosted its stake in shares of Ventas by 4.0% during the first quarter. Angeles Wealth Management LLC now owns 3,329 shares of the real estate investment trust’s stock valued at $274,000 after purchasing an additional 128 shares in the last quarter. IHT Wealth Management LLC raised its stake in Ventas by 3.2% in the fourth quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock worth $343,000 after buying an additional 137 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in Ventas by 1.2% in the first quarter. Sequoia Financial Advisors LLC now owns 12,894 shares of the real estate investment trust’s stock worth $1,054,000 after buying an additional 148 shares in the last quarter. Parallel Advisors LLC lifted its holdings in Ventas by 4.6% during the third quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock worth $278,000 after buying an additional 175 shares during the period. Finally, Manchester Capital Management LLC lifted its holdings in Ventas by 60.5% during the fourth quarter. Manchester Capital Management LLC now owns 491 shares of the real estate investment trust’s stock worth $38,000 after buying an additional 185 shares during the period. Hedge funds and other institutional investors own 94.18% of the company’s stock.
Ventas Trading Up 1.1%
NYSE:VTR opened at $92.82 on Friday. The stock has a market capitalization of $47.61 billion, a price-to-earnings ratio of 171.89, a PEG ratio of 2.12 and a beta of 0.69. Ventas, Inc. has a 52 week low of $66.38 and a 52 week high of $101.60. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The firm has a 50 day moving average of $91.18 and a 200 day moving average of $87.04.
Analyst Upgrades and Downgrades
A number of research analysts have recently issued reports on the company. UBS Group lifted their price target on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a report on Monday, May 4th. Mizuho boosted their price target on Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 22nd. Wells Fargo & Company upped their price objective on Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, July 21st. Finally, KeyCorp lifted their target price on Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $98.00.
View Our Latest Research Report on Ventas
Insider Buying and Selling at Ventas
In other Ventas news, Director Michael J. Embler acquired 2,500 shares of the stock in a transaction dated Wednesday, June 3rd. The stock was purchased at an average price of $78.81 per share, with a total value of $197,025.00. Following the transaction, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This trade represents a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.53% of the stock is owned by insiders.
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Further Reading
- Five stocks we like better than Ventas
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
